LGALS9 and experimental autoimmune encephalomyelitis: Although we have not identified an endogenous ligand in our study, previous studies have identified endogenous ligands of Dectin-1 in various disease models and cell types, such as Galectin-9 in a model of experimental autoimmune encephalomyelitis (Deerhake et al., 2021), annexins on apoptotic cells (Bode et al., 2019), and vimentin in atherosclerosis (Thiagarajan et al., 2013).